CJC-1295 (No DAC) Acetate (MOD GRF 1-29)
| Attribute | Detail |
|---|---|
| Catalog No. | [Insert Product Number Here] |
| Purity | >98% (Third-Party Tested HPLC/MS) |
| Form | Lyophilized Powder |
| Quantity | 2mg or 5mg [Select appropriate size] |
| CAS Number | 863288-34-0 |
⚠️ FOR LABORATORY RESEARCH USE ONLY ⚠️
This product is a research chemical intended strictly for in vitro and ex vivo laboratory experimentation. It is explicitly labeled "Not For Human Consumption."
Product Description
CJC-1295 (without DAC, Drug Affinity Complex), commonly referred to as MOD GRF 1-29, is a synthetic modified peptide consisting of the first 29 amino acids of the naturally occurring Growth Hormone-Releasing Hormone (GHRH). It is a stable, shorter-acting GHRH analogue compared to the version with DAC attached.
MOD GRF 1-29 functions as a potent GHRH secretagogue, stimulating the pituitary gland to release endogenous growth hormone (GH) in a pulsatile and natural manner within experimental models.
Scientific Research Applications
MOD GRF 1-29 is a widely used research tool in endocrinology and aging studies. Scientists use it in laboratory settings to investigate the mechanisms of GH regulation and its physiological effects in animal models and cell cultures.
Key research areas include:
- GH Pulsatility Studies: Researchers use MOD GRF 1-29 to investigate the natural, rhythmic secretion patterns of growth hormone and its subsequent impact on Insulin-like Growth Factor 1 (IGF-1) levels in animal subjects.
- Pituitary Function: Studies explore the peptide's interaction with the GHRH receptor in the anterior pituitary gland, offering insights into endocrine function in experimental cell lines.
- Metabolic Effects: Investigations in animal models focus on how increased endogenous GH release affects body composition, lipid metabolism, and overall cellular energy in lab subjects.
- Synergistic Effects: Researchers often study MOD GRF 1-29 in combination with ghrelin mimetics (like Ipamorelin) to explore potential synergistic effects on GH release pathways in experimental settings.
Technical Specifications
- Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
- Molecular Formula: C152H252N44O42S
- Storage: Store lyophilized powder at 2°C - 8°C. Upon reconstitution, store at 2°C - 8°C and use within [insert relevant timeframe, e.g., 8 days]. Protect from light.
Important Regulatory & Safety Information
- Unapproved Drug: MOD GRF 1-29 is a research chemical and an unapproved drug. It is not intended to diagnose, treat, cure, or prevent any disease.
- No Human Use Data: There is a lack of comprehensive human clinical safety data for this specific research chemical formulation. Its safety and efficacy in humans have not been established.
- Purchaser Responsibility: By purchasing this product, the buyer acknowledges they are a qualified researcher and assumes all liability for the use and handling of this research chemical. You must comply with all applicable laws and regulations in your jurisdiction.
